Stocks and Investing Stocks and Investing
Mon, September 27, 2021
Sun, September 26, 2021
Fri, September 24, 2021

Andrew Mok Initiated (AMED) at Strong Sell and Held Target at $150 on, Sep 24th, 2021


Published on 2024-10-27 17:59:49 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of UBS, Initiated "Amedisys, Inc." (AMED) at Strong Sell and Held Target at $150 on, Sep 24th, 2021.

Andrew has made no other calls on AMED in the last 4 months.



There are 7 other peers that have a rating on AMED. Out of the 7 peers that are also analyzing AMED, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Taylor of "Cowen & Co." Initiated at Hold and Held Target at $195 on, Friday, September 10th, 2021
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $237 on, Friday, August 6th, 2021
  • Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $220 on, Thursday, August 5th, 2021


These are the ratings of the 4 analyists that currently disagree with Andrew


  • A.J. Rice of "Credit Suisse" Maintained at Buy with Decreased Target to $250 on, Wednesday, August 11th, 2021
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $235 on, Tuesday, August 10th, 2021
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $250 on, Tuesday, August 10th, 2021
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $265 on, Friday, August 6th, 2021
Contributing Sources